RPMI-1640
货号: PM150110
Price: ¥58
产品信息
产品简介 | RPMI-1640是Moore等人于1967年在美国纽约州法罗市的罗斯韦尔公园纪念研究所(Roswell Park Memorial Institute, RPMI)开发出来的,RPMI是该研究所开发的一类细胞培养基,1640是培养基代号。RPMI-1640是改进型的McCoy's 5A培养基,使用碳酸氢盐缓冲系统,与大多数哺乳动物细胞培养基不同的是其典型的PH8的配方。RPMI-1640培养基最初是为淋巴细胞培养专门设计的,现在已广泛应用于各种正常细胞和癌细胞的培养,尤其是悬浮细胞的培养,是使用最为广泛的培养基之一。 本产品含有多类细胞培养所需的氨基酸、维生素、无机盐等多种成分,但不含蛋白质、脂类或任何生长因子,故此产品需搭配血清或无血清添加物使用。 |
产品浓度 | 1× |
产品规格 | 500 mL |
PH | 7.2-7.4 |
D-葡萄糖 | 2000mg/L |
HEPES | 无 |
L-谷氨酰胺 | 2mM |
NaHCO3 | 2000mg/L |
酚红 | 5mg/L |
内毒素含量(EU/mL) | <3 |
储存条件 | 2-8℃,避光储存 |
运输条件 | 常温 |
注意事项 |
|
-
Tumor microenvironment-responsive micelles assembled from a prodrug of mitoxantrone and 1-methyl tryptophan for enhanced chemo-immunotherapy(2023)
期刊:DRUG DELIVERY
DOI:10.1080/10717544.2023.2182254
影响因子:6.000
引用产品: RPMI-1640, Fetal Bovine Serum, 0.25% Trypsin Solution, Penicillin-Streptomycin Solution, 100×, Phosphate Buffer (PBS)
-
Urocortin2 attenuates diabetic coronary microvascular dysfunction by regulating macrophage extracellular vesicles(2023)
期刊:BIOCHEMICAL PHARMACOLOGY
影响因子:5.800
引用产品: Fetal Bovine Serum, RPMI-1640, DMEM(High glucose)
-
A1BG-AS1 promotes the biological functions of osteosarcoma cells via regulating the microRNA-148a-3p/USP22 axis and stabilizing the expression of SIRT1 through deubiquitinase function(2023)
期刊:EXPERT OPINION ON THERAPEUTIC TARGETS
DOI:10.1080/14728222.2023.2263908
影响因子:5.800
引用产品: U-2 OS [U2OS] Cells Line, Saos-2 Cells Line, MG-63 Cells Line, HOS Cells Line, SJSA-1 Cells Line, hFOB 1.19 Cells Line, McCoy's 5A, MEM, RPMI-1640, DMEM/F12
-
Verification of fasting-mimicking diet to assist monotherapy of human cancer-bearing models(2023)
期刊:BIOCHEMICAL PHARMACOLOGY
影响因子:5.800
引用产品: RPMI-1640
-
Endogenous NO-release multi-responsive hollow mesoporous silica nanoparticles for drug encapsulation and delivery(2023)
期刊:COLLOIDS AND SURFACES B-BIOINTERFACES
DOI:10.1016/j.colsurfb.2023.113346
影响因子:5.800
引用产品: Hela Cells Line, MCF7 [MCF-7] Cells Line, Fetal Bovine Serum, Penicillin-Streptomycin Solution, 100×, RPMI-1640, DMEM(High glucose)
-
Hypermethylation of RNF125 promotes autophagy-induced oxidative stress in asthma by increasing HMGB1 stability(2023)
期刊:iScience
DOI:10.1016/j.isci.2023.107503
影响因子:5.800
引用产品: RPMI-1640 Medium
-
NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma(2023)
期刊:iScience
DOI:10.1016/j.isci.2023.106531
影响因子:5.800
-
Long intergenic non-coding RNA DIO3OS promotes osteosarcoma metastasis via activation of the TGF-β signaling pathway: a potential diagnostic and immunotherapeutic target for osteosarcoma(2023)
期刊:Cancer Cell International
DOI:10.1186/s12935-023-03076-5
影响因子:5.800
引用产品: RPMI-1640 Medium, MEM, with NEAA Medium, DMEM (High glucose) Medium
-
Improvement of ACK1-targeted therapy efficacy in lung adenocarcinoma using chloroquine or bafilomycin A1(2023)
期刊:MOLECULAR MEDICINE
DOI:10.1186/s10020-023-00602-z
影响因子:5.700
引用产品: DMEM(High glucose), RPMI-1640
-
iNOS inhibitor S-methylisothiourea alleviates smoke inhalation-induced acute lung injury by suppressing inflammation and macrophage infiltration(2023)
期刊:INTERNATIONAL IMMUNOPHARMACOLOGY
DOI:10.1016/j.intimp.2023.111097
影响因子:5.600
引用产品: Human Umbilical Vein Endothelial cells, THP-1 Cells Line, RPMI-1640

识别码示意图